Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viewpoint: Discriminating between noncompetitive and allosteric interactions.

Raymond S Ochs1, Charles R Ashby

  • 1Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA. ochsr@stjohns.edu

Synapse (New York, N.Y.)
|December 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunotherapy Resistance in Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.

Cancer letters·2026
Same author

Vacuolization as a Novel Approach to Cancer Therapy.

Journal of biochemical and molecular toxicology·2026
Same author

The hidden hand of endoplasmic reticulum stress in anticancer drug resistance.

Critical reviews in oncology/hematology·2025
Same author

UB-221, an antibody that neutralizes IgE and downregulates the CD23 receptor: a potential treatment for the alpha-gal syndrome.

Ticks and tick-borne diseases·2025
Same author

Identification and Mechanistic Profiling of Indolin-2-One Derivatives That Induce ROS-Driven Intrinsic Apoptosis in Prostate and Colorectal Cancer Cells.

Journal of biochemical and molecular toxicology·2025
Same author

Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer.

Cancer biology & medicine·2025
Same journal

LncRNA MIAT Protects Against Sevoflurane-Induced Cognitive Dysfunction in Neonatal Rats via the miR-15b-5p/Ccnd1 Axis.

Synapse (New York, N.Y.)·2026
Same journal

A Survey of Automatic Sleep Staging: Technical Route, Technical Challenges, and Future Perspectives.

Synapse (New York, N.Y.)·2026
Same journal

Structural Architecture and Evolutionary Conservation of Cerebellin-Mediated Trans-Synaptic Signaling.

Synapse (New York, N.Y.)·2026
Same journal

Correction to "Time of Day Does Not Impact Spinal Serotonin Levels in Humans".

Synapse (New York, N.Y.)·2026
Same journal

Effect of Healthy Aging on the Cytoarchitecture of Layer V Pyramidal Neurons in the Motor Cortex of Rats: A Golgi Study.

Synapse (New York, N.Y.)·2026
Same journal

Ketamine Responsiveness of Mice Exhibiting Anorexia-Like Behavior Correlates With Synaptic AMPA Receptor Distribution.

Synapse (New York, N.Y.)·2026
See all related articles

Clarifying noncompetitive and allosteric inhibition is crucial in neuropharmacology. This study distinguishes between "not competitive" and "noncompetitive" inhibition, and clarifies noncompetitive from allosteric behavior for a stronger mechanistic basis.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Biochemistry

Background:

  • Understanding drug mechanisms is vital in neuropharmacology.
  • Confusion exists regarding inhibition modes beyond competitive inhibition.
  • Distinguishing between 'not competitive' and 'noncompetitive' inhibition is often unclear.

Purpose of the Study:

  • To clarify the terminology of noncompetitive and allosteric inhibition.
  • To differentiate between 'not competitive' and 'noncompetitive' inhibition.
  • To resolve confusion between noncompetitive and allosteric behavior in pharmacological systems.

Main Methods:

  • Literature review and conceptual analysis of inhibition kinetics.
  • Examination of enzyme inhibition models.
  • Discussion of allosteric modulation versus noncompetitive inhibition.

Related Experiment Videos

Main Results:

  • "Not competitive" is a broad category, while "noncompetitive" is a specific type of inhibition.
  • Noncompetitive inhibition can occur with or without affecting substrate binding.
  • Allosteric behavior involves binding at a secondary site, distinct from noncompetitive inhibition.

Conclusions:

  • A clear distinction between inhibition types provides a firmer mechanistic basis for understanding neuropharmacological systems.
  • Accurate terminology is essential for effective drug design and research.
  • Further research should emphasize precise definitions in kinetic studies.